Post by
lscfa on Apr 25, 2023 10:59am
Suspicious timing
Why not do the financing after the release of these clinical results and at a higher share price. Incompetence or self-enrichment?
Comment by
navajojoe on Apr 25, 2023 11:09am
This post has been removed in accordance with Community Policy
Comment by
Turtle4 on Apr 25, 2023 11:18am
I think they simply had no choice but to do the financing at that time.
Comment by
ark88 on Apr 25, 2023 11:24am
I agree, odd timing but the CEO did buy $500k of this offering which is pretty serious. Let's see if they have something material to release in the pipeline.